Mesothelioma Information and Support - Comprehensive Mesothelioma Information

Immunotherapy has emerged as a significant approach in the treatment of mesothelioma. One notable category within immunotherapy is checkpoint inhibitors, which play a pivotal role in blocking the evasion of...

Immunotherapy has emerged as a promising area of cancer treatment that leverages the body's own immune system to fight cancer cells. Unlike traditional chemotherapy, which often indiscriminately kills both cancerous...

Opdivo (nivolumab) and Yervoy (ipilimumab) are immunotherapy medications used to treat certain types of cancer. They work by helping the immune system fight cancer cells. While these medications are generally...

The combination therapy of Opdivo (nivolumab) and Yervoy (ipilimumab) offers a significant survival benefit for patients with unresectable mesothelioma compared to traditional chemotherapy. The combined treatment of Opdivo and Yervoy...

Checkpoint inhibitors represent a groundbreaking class of drugs in cancer immunotherapy, including for the treatment of mesothelioma. The PD-1/PD-L1 interaction is a normal mechanism that the body uses to prevent...

Dendritic cell therapy is a form of immunotherapy that has generated a lot of interest for its potential in treating various cancers, including mesothelioma. Dendritic cells act as messengers between...

Immunotherapy has been gaining traction as a treatment option for various types of cancers, including mesothelioma. However, please note that this list provided and its current status might have changed...

Two key factors that the FDA examines for treatment approval are the survival benefit and safety profile. Durvalumab in combination with chemotherapy resulted in a median survival of 20 months,...

There are various types of immunotherapy treatments available for patients with mesothelioma, a type of cancer most commonly affecting the lining of the lungs and abdomen. However, I must note...